Verisfield
Verisfield is a Greek pharmaceutical company that develops and markets generic pharmaceutical products. Founded in 2000 and headquartered in Athens, it operates as a private, for-profit firm with 51–100 employees serving the generics segment.
- Company typePrivate
- Founded2000
- HeadquartersAthína, Greece
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Verisfield does
Verisfield is a Greek pharmaceutical company that specialises in the development and marketing of generic pharmaceutical products. Founded in 2000 and headquartered in Athína (Athens), the company operates as a for-profit private entity with a headcount of 51–100 employees. Its business model is anchored in the generics segment, where value is created by developing, registering, and commercialising off-patent pharmaceutical products for therapeutic substitution at lower price points than originator brands.
The input source material returned a loading/verification page rather than substantive company content, and most standard data fields — revenue, leadership, product list, partnerships, funding, technology stack, geographic footprint, certifications, and customer base — are not populated. As a result, the technical architecture, specific product portfolio, regulatory authorisations, distribution channels, and end-customer segments are not documented. Operating geography is limited to a single disclosed location (Athens), and the website domain (verisfield.gr) suggests a primary Greek market orientation, though export activity cannot be confirmed from the available data.
Revenue mechanics, pricing model, and go-to-market motion are not disclosed. In the absence of named customers, distribution partners, or contract-value data, customer-acquisition strategy and revenue predictability cannot be assessed. Investment-relevant unknowns include ownership structure, key therapeutic categories, marketing-authorisation footprint across EU/EEA or other jurisdictions, and whether the company is primarily a developer (own dossiers) or a distributor/marketer of in-licensed generics.
Verisfield firmographics
Firmographics- Name
- Verisfield
- Website
- https://verisfield.gr
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Verisfield is a Greek pharmaceutical company that develops and markets generic pharmaceutical products. Founded in 2000 and headquartered in Athens, it operates as a private, for-profit firm with 51–100 employees serving the generics segment.
- Ownership category
- akta.pro rank
Verisfield industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
Keywords
Where Verisfield is headquartered
LocationHeadquarters
- HQ city
- Athína
- HQ country
- Greece
- HQ region
- Europe
Markets served
Verisfield business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Verisfield product offering
Product offeringCore offering
Verisfield is a private pharmaceutical company headquartered in Athens, Greece, that specializes in the development and marketing of generic pharmaceutical products. The company focuses on bringing generic equivalents of established pharmaceutical formulations to market. With a workforce of 51-100 employees, it operates as a for-profit business entity serving the pharmaceutical sector.
Differentiator
Problem solved
Functional benefit
Companies that use Verisfield
Customer profileIdeal customer profiles1 record
Verisfield technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Verisfield competitors and assessment
Company assessmentBroad incumbents
- STADA Arzneimittel: European-focused generic and consumer healthcare company, now PE-owned. Comparable in EU generics focus and mid-sized European footprint, though at much larger scale; an active consolidator in the segment.
- Alvogen: US-headquartered but with significant European generics operations and a portfolio-builder strategy. Comparable in generics focus and active M&A-driven expansion across European markets.
- Sandoz (Novartis): Global leader in generics and biosimilars, spun off from Novartis. Comparable product category with strong European commercial presence; represents the upper bound of generic scale and pricing power.
- KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with strong Central/Eastern European presence. Comparable in generics-only model and European regional orientation.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical company with broad portfolio across all therapeutic areas. Comparable product category but vastly larger scale and global reach; sets the competitive benchmark for European generic pricing.
Direct peers
- Lavipharm: Greek pharmaceutical group with generics, OTC, and consumer healthcare products. Comparable in Greek home market presence, generics portfolio, and mid-cap size profile.
- Specifar Pharmaceuticals (Aenova): Greek-based generic pharmaceutical company specializing in development and manufacturing of generics, now part of Aenova Group. Closely comparable generics developer-marketer with Greek footprint.
- Help Pharmaceuticals: Greek pharmaceutical company marketing generic and OTC products domestically and in regional markets. Comparable in size, generics focus, and Greek/EU distribution orientation.
- ELPEN Pharmaceutical Co. Greek-based pharmaceutical company focused on branded generics and specialty products with in-house manufacturing. Directly comparable to Verisfield in terms of geography, generics focus, and mid-sized European footprint.
- DEMO Pharmaceuticals: One of Greece's largest generic pharmaceutical manufacturers with strong development and export capabilities. Highly comparable in product category (sterile generics and injectables) and Greek home market positioning.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks1 record
Key highlights1 record
Customer concentration
Verisfield social profiles
Digital presenceVerisfield financial estimates
Financial estimateRevenue estimate
Valuation estimate
Verisfield leadership team
Management profileNumber of profiles
Verisfield funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Verisfield M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Verisfield
What does Verisfield do?
Verisfield is a private pharmaceutical company headquartered in Athens, Greece, that specializes in the development and marketing of generic pharmaceutical products. The company focuses on bringing generic equivalents of established pharmaceutical formulations to market. With a workforce of 51-100 employees, it operates as a for-profit business entity serving the pharmaceutical sector.
When was Verisfield founded?
Verisfield was founded in 2000. It employs 51 to 100 people.
Where is Verisfield based?
Verisfield is headquartered in Athína, Greece, in the Europe region.
Who are Verisfield's main competitors?
Broad incumbents on record are STADA Arzneimittel, Alvogen, Sandoz (Novartis), KRKA and Teva Pharmaceutical Industries. Direct peers are Lavipharm, Specifar Pharmaceuticals (Aenova), Help Pharmaceuticals, ELPEN Pharmaceutical Co. and DEMO Pharmaceuticals.
Does Verisfield have an API?
No public API is recorded for Verisfield.
What industry is Verisfield in?
Verisfield's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 325412 and its SIC code is 5122.